Czekalski Stanislaw, Hozejowski Roman
Department of Nephrology, Transplantology and Internal Diseases, University of Medical Sciences, Poznań, Poland.
J Ren Nutr. 2004 Apr;14(2):82-8. doi: 10.1053/j.jrn.2004.01.007.
Prospective evaluation of the effect of 6-month-long intradialytic amino acids (AA) supplementation on selected nutritional variables in malnourished hemodialysis (HD) patients.
Multicenter, prospective, (nonrandomized, noncontrolled) observational study.
Thirty-one HD units affiliated with academic centers and tertiary-care hospitals.
Adult patients treated by HD for at least 6 months. Inclusion criteria were: serum albumin concentration < or =39 g/L and at least 4% loss of body weight during the last 6 months in otherwise stable HD patients. From a cohort of 133 patients who were enrolled, 97 (54 men and 43 women) were eligible for the analysis.
Intradialytic AA supplementation with 500 mL 10% solution per HD session for a period of 6 months.
Serum albumin concentration, modified Subjective Global Assessment (SGA) score, body mass index (BMI), mid-arm circumference (MAC), and total lymphocyte count. Measurements were recorded at baseline and after 3 and 6 months of AA supplementation.
Serum albumin concentration increased significantly from the mean 32.5 +/- 4.6g/L at baseline to 36.4 +/- 4.8 g/L at 3 months (P <.001) and 37.1 +/- 4.8 g/L at final observation (P <.001 versus baseline). Significant correlation was observed between frequency of AA supplementation and serum albumin increase (r = 0.41; P <.0001). Rate of improvement negatively correlated significantly with baseline concentration of serum albumin (r = - 0.42; P <.0001). SGA score significantly improved from median of 16 points at baseline to 12 points at 3 months (P <.01) and 11 points at 6 months (P <.01 versus baseline), and this improvement also correlated with the frequency of AA supplementation. Small yet significant increase of MAC was observed at 6 months (from baseline 24.1 +/- 4.3 to 24.8 +/- 4.8 cm; P <.01), whereas BMI remained unchanged.
Intradialytic AA supplementation improves selected nutritional parameters of HD patients with malnutrition. The improvement depends on the intensity of supplementation.
前瞻性评估为期6个月的透析期间补充氨基酸(AA)对营养不良的血液透析(HD)患者选定营养变量的影响。
多中心、前瞻性(非随机、非对照)观察性研究。
隶属于学术中心和三级护理医院的31个HD单位。
接受HD治疗至少6个月的成年患者。纳入标准为:血清白蛋白浓度≤39g/L,且在其他方面稳定的HD患者在过去6个月内体重减轻至少4%。在133名入组患者中,97名(54名男性和43名女性)符合分析条件。
每次HD治疗期间透析中补充500mL 10%溶液,为期6个月。
血清白蛋白浓度、改良主观全面评定法(SGA)评分、体重指数(BMI)、上臂中部周长(MAC)和总淋巴细胞计数。在基线以及补充AA 3个月和6个月后记录测量值。
血清白蛋白浓度从基线时的平均32.5±4.6g/L显著增加至3个月时的36.4±4.8g/L(P<.001),最终观察时为37.1±4.8g/L(与基线相比P<.001)。观察到补充AA的频率与血清白蛋白增加之间存在显著相关性(r = 0.41;P<.0001)。改善率与血清白蛋白的基线浓度呈显著负相关(r = -0.42;P<.0001)。SGA评分从基线时的中位数16分显著改善至3个月时的12分(P<.01)和6个月时的11分(与基线相比P<.01),且这种改善也与补充AA的频率相关。6个月时观察到MAC有小幅但显著的增加(从基线时的24.1±4.3增加至24.8±4.8cm;P<.01),而BMI保持不变。
透析期间补充AA可改善营养不良的HD患者的选定营养参数。改善情况取决于补充的强度。